Skip to main content

Opdivo 120 mg/12 mL injection for intravenous use Images

Generic Name: nivolumab

This medication has been identified as Opdivo 120 mg/12 mL injection for intravenous use. It is supplied by Bristol-Myers Squibb Company.

Opdivo is used in the treatment of Esophageal Carcinoma; Colorectal Cancer; Head and Neck Cancer; Hepatocellular Carcinoma; Hodgkin's Lymphoma and belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors). Opdivo 120 mg/12 mL injection for intravenous use is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Opdivo 120 mg/12 mL injection for intravenous use medicine

Opdivo

Generic Name
nivolumab
Strength
120 mg/12 mL injection for intravenous use
Availability
Prescription only
Drug Class
Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb Company
National Drug Code (NDC)
00003-3756

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.